文献速递妇科

最大化前哨淋巴结检出:子宫内膜癌主动脉前哨淋巴结检出

Maximizing Sentinel Lymph Node Detection: Aortic Sentinel Lymph Node Detection in Endometrial Cancer.
PubMed 文献 · J Minim Invasive Gynecol · 2018-03-02

本研究通过视频逐步演示一例60岁IAG1子宫内膜腺癌患者接受宫颈及宫底双路径吲哚菁绿注射后行腹主动脉旁及盆腔前哨淋巴结检出的手术过程,最终病理升级为IIIC2期,作者认为双路径注射可全面检出盆腔及腹主动脉旁前哨淋巴结,但其附加获益的重要性仍需进一步评估。

要点

  • 宫颈联合宫底双路径吲哚菁绿注射可同时评估盆腔及腹主动脉旁前哨淋巴结。
  • 该技术不增加相关并发症,但与手术时间延长相关。
  • 腹主动脉旁前哨淋巴结转移发生率低,其临床意义仍在讨论中。

核心结论

  • 双路径吲哚菁绿注射可全面检出子宫内膜癌盆腔及腹主动脉旁前哨淋巴结,最大化识别所有可能受累区域,但其附加获益的重要性仍需进一步评估。

研究设计与样本

  • 研究采用视频描述及逐步演示手术过程(加拿大工作组分类III级),于西班牙圣塞巴斯蒂安Donostia大学医院开展。
  • 患者为60岁女性,诊断为IAG1子宫内膜腺癌,在研究方案框架内接受宫颈及经宫颈宫底吲哚菁绿注射以检出腹主动脉旁及盆腔前哨淋巴结,随后按标准方案行全子宫切除及双侧输卵管卵巢切除加子宫冰冻切片。
  • 本研究的研究方案已获机构审查委员会批准。

主要发现

  • 双路径吲哚菁绿注射在宫颈注射(最佳评估盆腔区域)基础上增加宫底注射,可更好扩散至腰主动脉路径,避免遗漏主动脉引流及主动脉前哨淋巴结。
  • 最终组织学分类升级为IIIC2期子宫内膜癌,即主动脉及盆腔右侧直肠旁间隙微转移,肿瘤3 cm G1,无淋巴血管侵犯。
  • 该技术不增加相关并发症,但与手术时间延长相关。
  • 盆腔前哨淋巴结解剖中,耐心与良好培训是关键;若经典区域未检出前哨淋巴结,术者须始终警惕不常见路径。

临床怎么用

  • 作者认为双路径吲哚菁绿注射可全面检出盆腔及腹主动脉旁前哨淋巴结,最大化识别所有可能受累区域。
  • 作者认为该技术不增加相关并发症,但与手术时间延长相关。
  • 作者认为其附加获益的重要性仍需进一步评估。

局限性

  • 原文报告腹主动脉旁前哨淋巴结转移发生率低,其相关性仍在讨论中。
  • 原文指出双路径注射附加获益的重要性仍需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To determine the importance of a dual (cervical and fundal) indocyanine green (ICG) injection and thorough dissection for the detection of sentinel lymph nodes (SLNs). DESIGN: Description and step-by-step demonstration of the surgical procedure using video (Canadian Task Force classification III). SETTING: Hospital Universitario Donostia, San Sebastián, Spain. PATIENTS: A 60-year-old woman with a diagnosis of IAG1 endometrial adenocarcinoma (EC). INTERVENTIONS: The patient received a cervical and transcervical fundal ICG injection for para-aortic and pelvic SLN detection in the setting of a research protocol, followed by a total hysterectomy and bilateral salpingo-oophorectomy with a frozen section of the uterus as a standard approach [1]. Institutional Review Board approval was obtained for the research protocol of this study. MEASUREMENTS AND MAIN RESULTS: Dual ICG injection [2] adds the benefit of a cervical injection (that best evaluates the pelvic region [3]) to the fundal injection, with better spread to the lumboaortic pathway [4] so as not to lose the aortic drainage and aortic SLN, whose relevance is still discussed due to its low incidence of metastasis [5]. This search does not add to the associated morbidity but is associated with increased operative time. For pelvic SLN dissection, patience and good training are key; the surgeon must always be on the lookout for uncommon pathways if no SLN is detected in the classical areas. The final histological classification was upgraded to a grade IIIC2 (ie, micrometastasis in the aortic and pelvic-right pararectal space) EC, 3 cm G1 with no lymphovascular invasion. CONCLUSION: Dual ICG injection allows comprehensive mapping not only of pelvic SLNs, but also of para-aortic SLNs, in EC, maximizing the identification of all possible affected areas. Nonetheless, the relevance of its added benefit requires further evaluation.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Gorostidi M, Villalain C, Ruiz R, et al. Maximizing Sentinel Lymph Node Detection: Aortic Sentinel Lymph Node Detection in Endometrial Cancer. J Minim Invasive Gynecol. 2018. PMID: 29501809. doi:10.1016/j.jmig.2018.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。